Complete Metabolic Response with Recanalization of Portal Vein Tumor Thrombosis after Sunitinib in a Patient with Advanced Hepatocellular Carcinoma
The prognosis of patients with advanced hepatocellular carcinoma (HCC) is very poor. The outcome of these patients is particularly bleak when the disease is complicated by portal vein tumor thrombosis (PVTT), since the increased portal pressure often causes serious gastrointestinal bleedings. Before...
Main Authors: | Michele Basso, Maria Basso, Alessandro Iaculli, Maurizio Pompili, Laura Riccardi, Brunella Barbaro, Vittoria Rufini, Alessandra Cassano, Paola Castaldi, Carlo Barone |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2010-11-01
|
Series: | Case Reports in Oncology |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/322135 |
Similar Items
-
Treatment-related adverse effects with pazopanib, sorafenib and sunitinib in patients with advanced soft tissue sarcoma: a pooled analysis
by: Que Y, et al.
Published: (2018-07-01) -
Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis
by: Moon Haeng Hur, et al.
Published: (2023-07-01) -
Efficacy of Liver-Directed Combined Radiotherapy in Locally Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
by: Jina Kim, et al.
Published: (2023-06-01) -
Skeletal Muscle Loss during Multikinase Inhibitors Therapy: Molecular Pathways, Clinical Implications, and Nutritional Challenges
by: Emanuele Rinninella, et al.
Published: (2020-10-01) -
PORTAL VEIN THROMBOSIS-ULTRASOUND IMAGING
by: Trajkovska Meri, et al.
Published: (2016-07-01)